Table 3.
AP | OP | p Value | Effect Size | |
---|---|---|---|---|
Myogenesis | ||||
MyoD | 1.00 ± 0.11 | 1.53 ± 0.94 | 0.39 | 0.63 |
Myogenin | 1.03 ± 0.31 | 1.12 ± 0.23 | 0.72 | 0.25 |
Pax7 | 1.20 ± 0.92 | 0.79 ± 0.16 | 0.48 | 0.51 |
Myf5 | 1.17 ± 0.85 | 0.89 ± 0.14 | 0.60 | 0.35 |
Myf6 | 1.10 ± 0.52 | 0.96 ± 0.43 | 0.74 | 0.24 |
Proteolysis | ||||
MAFbx | 1.10 ± 0.50 | 0.94 ± 0.24 | 0.66 | 0.31 |
MuRF1 | 1.04 ± 0.34 | 0.66 ± 0.23 | 0.18 | 1.05 |
1 Values are the mean ± SD. Differences between AP (n = 3; n = 2 for Myf5) and OP (n = 3) were examined using unpaired t tests. AP, adequate protein; MAFbx, muscle atrophy F-box; MuRF1, muscle RING finger−1; Myf5, myogenic factor 5; Myf6, myogenic factor 6; OP, optimal protein; Pax7, paired box 7.